EGFR overexpression, frequently observed in NSCLC and other solid tumors, has been associated with disease aggressiveness, higher recurrence rates, and unfavorable prognosis [6,7,8,9,10]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.